Thyroid Clinical Trials in Shanghai, Shanghai Municipality
23 recruitingShanghai, Shanghai Municipality, China
Showing 1–20 of 23 trials
Recruiting
Phase 3
Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
Thyroid Eye Disease (TED)
Minghui Pharmaceutical (Hangzhou) Ltd258 enrolled1 locationNCT07262476
Recruiting
Phase 3
MHB018A Treatment in Patients With Active Thyroid Eye Disease
Thyroid Associated Ophthalmopathies
Minghui Pharmaceutical (Hangzhou) Ltd108 enrolled1 locationNCT06989918
Recruiting
Phase 4
Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules
Thyroid Nodule
Xintian Pharmaceutical234 enrolled22 locationsNCT06423235
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Lung CancerPancreas CancerThyroid Cancer+1 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 1
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
SafetyTolerabilityGenSci098+1 more
Changchun GeneScience Pharmaceutical Co., Ltd.76 enrolled1 locationNCT06569758
Recruiting
Phase 3
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Thyroid Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.144 enrolled35 locationsNCT06860971
Recruiting
Phase 2
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
Thyroid Cancer
Fudan University60 enrolled1 locationNCT07235566
Recruiting
Phase 3
Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Secondary Hyperparathyroidism, Chronic Kidney Disease
Shaanxi Micot Pharmaceutical Technology Co., Ltd.424 enrolled1 locationNCT07122401
Recruiting
Phase 4
Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital50 enrolled1 locationNCT07152392
Recruiting
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
Obesity and OverweightMetabolic SyndromeHypertension+6 more
Shanghai Changzheng Hospital4,094 enrolled1 locationNCT07043166
Recruiting
Phase 4
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital64 enrolled2 locationsNCT07152340
Recruiting
Phase 4
A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
Advanced Thyroid Cancer Patients Who Received Target Therapy
Fudan University800 enrolled8 locationsNCT06195228
Recruiting
Gongji Pregnancy Endorine Cohort Study
Gestatiaonl Diabetes MellitusThyroid Disease PregnancyHyperglycemia in Pregnant Diabetic Patients
Shanghai General Hospital, China3,000 enrolled1 locationNCT07125885
Recruiting
Phase 2
Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer
Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation
Fudan University40 enrolled1 locationNCT06970353
Recruiting
Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
Thyroid Associated Ophthalmopathy
Shanghai Changzheng Hospital150 enrolled1 locationNCT06590220
Recruiting
Postoperative Pain of Robotic, Endoscopic and Open Lateral Neck Dissection
SurgeryPain, PostoperativeThyroid Diseases
Shanghai 6th People's Hospital600 enrolled1 locationNCT06803732
Recruiting
Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
Differentiated Thyroid Cancer
Shanghai 6th People's Hospital500 enrolled1 locationNCT06671184
Recruiting
The Value of 68Ga-FAPI PET/CT in Detecting Recurrent and Metastatic Lesions in Patients with Thyroid Cancer After Surgery
Thyroid Cancer
Ruijin Hospital40 enrolled1 locationNCT06800768
Recruiting
The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
Thyroid Cancer
Ruijin Hospital40 enrolled1 locationNCT06730529
Recruiting
Phase 2
Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer
Differentiated Thyroid Cancer
Fudan University32 enrolled1 locationNCT05989425